- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AB Science (ABS)
AB Science stock price live, this page displays EPA ABS stock exchange data. View the ABS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AB Science real time stock price chart below.
What Is the AB Science Stock Price Today?
The AB Science stock price today is 1.39.
What Is the Stock Symbol for AB Science?
The stock symbol for AB Science is ""ABS.""
What Stock Exchange Does AB Science Trade On?
AB Science is listed and trades on the Paris stock exchange.
Is AB Science a Good Stock to Buy?
Determining whether AB Science—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABS quote. (ISIN: FR0010557264)
What Is the AB Science Stock Price Today?
The AB Science stock price today is 1.39.
What Is the Stock Symbol for AB Science?
The stock symbol for AB Science is ""ABS.""
What Stock Exchange Does AB Science Trade On?
AB Science is listed and trades on the Paris stock exchange.
Is AB Science a Good Stock to Buy?
Determining whether AB Science—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABS quote. (ISIN: FR0010557264)
Paris
Currency in EUR
1.39
+0.09(+6.91%)
Closed·
Fair Value
An estimate of a AB Science's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.32
1.44
52 wk Range
0.77
2.34
ABS Scorecard
Full Analysis
Significant return over the last week
ABS is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a AB Science's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.321.44
52 wk Range
0.772.34
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a AB Science's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
2.54
Upside
+82.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
AB Science Company Profile
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France. The company’s lead drug candidate is masitinib, a selective protein kinase inhibitor that targets mast cells and microglia in Phase 3 trial for the treatment of amyotrophic lateral sclerosis, progressive forms of multiple sclerosis, Alzheimer’s disease, and indolent systemic mastocytosis, as well as in Phase 2 trial for mast cell activation syndrome and sickle cell disease. It also develops AB8939, a microtubule destabilizer in Phase 1 trial for the treatment of acute myeloid leukemia; and AB12319 in preclinical trial to treat sarcoma and solid tumors. In addition, the company markets its masitinib under the Masivet brand for the treatment of mast cell tumors in dogs in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
AB Science Earnings Call Summary for Q4/2024
- Q4 2024 sales revenue up 29% YoY to NOK 43.5M; gross margin improved to 32.7%
- Adjusted EBITDA negative at -NOK 36.8M, but improved from -NOK 38.6M in 2023
- European market grew 50% YoY, accounting for 43% of total revenue; B2B segment 89% of sales
- Company anticipates becoming cash-positive by 2026; Omega Beauty product launch planned for H1 2025
- HEROPA clinical trial 12-month readout expected in March, crucial for future growth prospects
Last Updated: 27/02/2025, 12:26
Read Full TranscriptCompare ABS to Peers and Sector
Metrics to compare | ABS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.0x | 15.4x | −0.5x | |
PEG Ratio | −0.32 | 0.05 | 0.00 | |
Price/Book | −3.9x | 1.6x | 2.6x | |
Price / LTM Sales | 87.5x | 2.6x | 3.2x | |
Upside (Analyst Target) | 82.7% | 21.6% | 41.4% | |
Fair Value Upside | Unlock | 14.5% | 6.0% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 2.54
(+82.73% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
512.00K / --
People Also Watch
FAQ
What Stock Exchange Does AB Science Trade On?
AB Science is listed and trades on the Paris Stock Exchange stock exchange.
What Is the Stock Symbol for AB Science?
The stock symbol for AB Science is "ABS."
What Is the AB Science Market Cap?
As of today, AB Science market cap is 93.67M.
What Is AB Science's Earnings Per Share (TTM)?
The AB Science EPS (TTM) is -0.15.
From a Technical Analysis Perspective, Is ABS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has AB Science Stock Split?
AB Science has split 0 times.
How Many Employees Does AB Science Have?
AB Science has 34 employees.
What is the current trading status of AB Science (ABS)?
As of 27 Jul 2025, AB Science (ABS) is trading at a price of 1.39, with a previous close of 1.30. The stock has fluctuated within a day range of 1.32 to 1.44, while its 52-week range spans from 0.77 to 2.34.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.